CoChat

Gender Differences in Psychotropic Use Across Europe: Results From a Large Cross-Sectional, Population-Based Study

Open access
Boyd, A., Van de Velde, S., Pivette, M., ten Have, M., Florescu, S., O’Neill, S., Caldas-de-Almeida, J.-M., Vilagut, G., Haro, J.M., Alonso, J., Kovess-Masféty, V. · 2015 · European Psychiatry
Cited by 90

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Background: In many epidemiological studies, women have been observed to consume psychotropic medication more often than men. However, the consistency of this relationship across Europe, with differences in mental health care (MHC) resources and reimbursement policies, is unknown. Methods: Questions on 12-month psychotropic use (antidepressants, benzodiazepines, antipsychotics, mood stabilizers) were asked to 34,204 respondents from 10 European countries of the EU-World Mental Health surveys. Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) criteria were used to determine 12-month prevalence of mood/anxiety disorders using the Composite International Diagnostic Interview (v3.0). Results: For all participating countries, women were significantly more likely than men to use psychotropic medication within the previous 12 months (overall-OR = 2.04, 95% CI: 1.81–2.31). This relationship remained significant after adjusting for common sociodemographic factors (age, income level, employment status, education, marital status) and country-level indicators (MHC provision, private household out-of-pocket expenditure, and Gender Gap Index). In multivariable gender-stratified risk-factor analysis, both women and men were more likely to have taken psychotropic medication with increasing age, decreasing income level, and mental health care use within the past 12 months, with no significant differences between genders. When only including participants with a mental disorder, gender differences overall were still significant with any 12-month mood disorder but not with any 12-month anxiety disorder, remaining so after adjusting for sociodemographic characteristics and country-level indicators. Conclusions: Women use psychotropic medication consistently more often than men, yet reasons for their use are similar between genders. These differences also appear to be contingent on the specific mental disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.eurpsy.2015.05.001

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 90

Metadata

Authors
Boyd, A., Van de Velde, S., Pivette, M., ten Have, M., Florescu, S., O’Neill, S., Caldas-de-Almeida, J.-M., Vilagut, G., Haro, J. M., Alonso, J., & Kovess-Masféty, V.
Venue
European Psychiatry
Published
2015-07-04
Volume
30
Issue
6
Pages
778-788
ISSN
  • 0924-9338 (ISSN-L)
  • 1778-3585
OpenAlex
W1897424646
Cited by
90
References
13
FWCI
7.30
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gender Differences in Psychotropic Use Across Europe: Results From a Large Cross-Sectional, Population-Based Study. https://app.cochat.ai/papers/10.1016/j.eurpsy.2015.05.001
The paper
Boyd, A., Van de Velde, S., Pivette, M., ten Have, M., Florescu, S., O’Neill, S., Caldas-de-Almeida, J.-M., Vilagut, G., Haro, J. M., Alonso, J., & Kovess-Masféty, V. (2015). Gender Differences in Psychotropic Use Across Europe: Results From a Large Cross-Sectional, Population-Based Study. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2015.05.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.